世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ロミデプシンの世界市場の洞察、2028年までの予測

ロミデプシンの世界市場の洞察、2028年までの予測


Global Romidepsin Market Insights, Forecast to 2028

ロミデプシンは、ヒストン脱アセチル化酵素(HDAC)阻害剤で、がんの治療に使用されます。 市場分析とインサイトロミデプシンの世界市場 COVID-19のパンデミックにより、Romidepsinの世界市場規模は2022年に100... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2022年1月28日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

ロミデプシンは、ヒストン脱アセチル化酵素(HDAC)阻害剤で、がんの治療に使用されます。
市場分析とインサイトロミデプシンの世界市場
COVID-19のパンデミックにより、Romidepsinの世界市場規模は2022年に100万米ドルと推定され、検討期間中のCAGRは%で2028年までに再調整されて100万米ドルになると予測されています。この健康危機による経済的変化を十分に考慮し、2021年のRomidepsin世界市場の%を占める0.98は、COVID-19以降の期間に改訂された%のCAGRで成長し、2028年には100万米ドルになると予測されています。一方、生物学的製剤の分野は、この予測期間中、年率%で変化しています。
中国のRomidepsinの市場規模は2021年に百万米ドル、米国と欧州のRomidepsinはそれぞれ百万米ドルと百万米ドルとなっています。米国の割合は2021年には%ですが、中国と欧州はそれぞれ%と%で、中国の割合は2028年には%に達し、分析期間中のCAGRは%になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。ヨーロッパのRomidepsin市場では、ドイツが2028年までに100万米ドルに達すると予測されています(予測期間中のCAGRは%です)。
ロミデプシンの世界的な主要メーカーには、Merck Group、BPS Bioscience, Inc.、Selleck Chemicals、AdooQ BioScience、Cayman Chemical Company、Santa Cruz Biotechnology, Inc.、Apexbio Technology LLC、TargetMol Chemicals Inc、InvivoChem LLCなどがあります。2021年には、世界の上位5社の売上高シェアは約%となっています。
世界のロミデプシンのスコープとセグメント
ロミデプシン市場は、タイプ別、アプリケーション別に分類されています。世界のRomidepsin市場に参加するプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年の期間におけるタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。
タイプ別セグメント
0.98
>98%
アプリケーション別セグメント
バイオロジカル
メディカル
会社別
メルクグループ
BPSバイオサイエンス社
Selleck Chemicals
AdooQバイオサイエンス
ケイマン・ケミカル社
サンタクルーズ・バイオテクノロジー社
アペックスバイオ・テクノロジー社
ターゲットモル・ケミカルズ社
インビボケムLLC
Cckinase, Inc.
上海ロラン生物技術有限公司
上海レッケムサイエンス有限公司
大連美潤生物技術有限公司
寧波イノ・ファームケム社
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
UAE


ページTOPに戻る


目次

1 Study Coverage
1.1 Romidepsin Product Introduction
1.2 Market by Type
1.2.1 Global Romidepsin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 0.98
1.2.3 >98%
1.3 Market by Application
1.3.1 Global Romidepsin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Biological
1.3.3 Medical
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Romidepsin Sales Estimates and Forecasts 2017-2028
2.2 Global Romidepsin Revenue Estimates and Forecasts 2017-2028
2.3 Global Romidepsin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Romidepsin Sales by Region
2.4.1 Global Romidepsin Sales by Region (2017-2022)
2.4.2 Global Sales Romidepsin by Region (2023-2028)
2.5 Global Romidepsin Revenue by Region
2.5.1 Global Romidepsin Revenue by Region (2017-2022)
2.5.2 Global Romidepsin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Romidepsin Sales by Manufacturers
3.1.1 Global Top Romidepsin Manufacturers by Sales (2017-2022)
3.1.2 Global Romidepsin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Romidepsin in 2021
3.2 Global Romidepsin Revenue by Manufacturers
3.2.1 Global Romidepsin Revenue by Manufacturers (2017-2022)
3.2.2 Global Romidepsin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Romidepsin Revenue in 2021
3.3 Global Romidepsin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Romidepsin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Romidepsin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Romidepsin Sales by Type
4.1.1 Global Romidepsin Historical Sales by Type (2017-2022)
4.1.2 Global Romidepsin Forecasted Sales by Type (2023-2028)
4.1.3 Global Romidepsin Sales Market Share by Type (2017-2028)
4.2 Global Romidepsin Revenue by Type
4.2.1 Global Romidepsin Historical Revenue by Type (2017-2022)
4.2.2 Global Romidepsin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Romidepsin Revenue Market Share by Type (2017-2028)
4.3 Global Romidepsin Price by Type
4.3.1 Global Romidepsin Price by Type (2017-2022)
4.3.2 Global Romidepsin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Romidepsin Sales by Application
5.1.1 Global Romidepsin Historical Sales by Application (2017-2022)
5.1.2 Global Romidepsin Forecasted Sales by Application (2023-2028)
5.1.3 Global Romidepsin Sales Market Share by Application (2017-2028)
5.2 Global Romidepsin Revenue by Application
5.2.1 Global Romidepsin Historical Revenue by Application (2017-2022)
5.2.2 Global Romidepsin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Romidepsin Revenue Market Share by Application (2017-2028)
5.3 Global Romidepsin Price by Application
5.3.1 Global Romidepsin Price by Application (2017-2022)
5.3.2 Global Romidepsin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Romidepsin Market Size by Type
6.1.1 North America Romidepsin Sales by Type (2017-2028)
6.1.2 North America Romidepsin Revenue by Type (2017-2028)
6.2 North America Romidepsin Market Size by Application
6.2.1 North America Romidepsin Sales by Application (2017-2028)
6.2.2 North America Romidepsin Revenue by Application (2017-2028)
6.3 North America Romidepsin Market Size by Country
6.3.1 North America Romidepsin Sales by Country (2017-2028)
6.3.2 North America Romidepsin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Romidepsin Market Size by Type
7.1.1 Europe Romidepsin Sales by Type (2017-2028)
7.1.2 Europe Romidepsin Revenue by Type (2017-2028)
7.2 Europe Romidepsin Market Size by Application
7.2.1 Europe Romidepsin Sales by Application (2017-2028)
7.2.2 Europe Romidepsin Revenue by Application (2017-2028)
7.3 Europe Romidepsin Market Size by Country
7.3.1 Europe Romidepsin Sales by Country (2017-2028)
7.3.2 Europe Romidepsin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Romidepsin Market Size by Type
8.1.1 Asia Pacific Romidepsin Sales by Type (2017-2028)
8.1.2 Asia Pacific Romidepsin Revenue by Type (2017-2028)
8.2 Asia Pacific Romidepsin Market Size by Application
8.2.1 Asia Pacific Romidepsin Sales by Application (2017-2028)
8.2.2 Asia Pacific Romidepsin Revenue by Application (2017-2028)
8.3 Asia Pacific Romidepsin Market Size by Region
8.3.1 Asia Pacific Romidepsin Sales by Region (2017-2028)
8.3.2 Asia Pacific Romidepsin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Romidepsin Market Size by Type
9.1.1 Latin America Romidepsin Sales by Type (2017-2028)
9.1.2 Latin America Romidepsin Revenue by Type (2017-2028)
9.2 Latin America Romidepsin Market Size by Application
9.2.1 Latin America Romidepsin Sales by Application (2017-2028)
9.2.2 Latin America Romidepsin Revenue by Application (2017-2028)
9.3 Latin America Romidepsin Market Size by Country
9.3.1 Latin America Romidepsin Sales by Country (2017-2028)
9.3.2 Latin America Romidepsin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Romidepsin Market Size by Type
10.1.1 Middle East and Africa Romidepsin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Romidepsin Revenue by Type (2017-2028)
10.2 Middle East and Africa Romidepsin Market Size by Application
10.2.1 Middle East and Africa Romidepsin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Romidepsin Revenue by Application (2017-2028)
10.3 Middle East and Africa Romidepsin Market Size by Country
10.3.1 Middle East and Africa Romidepsin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Romidepsin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck Group
11.1.1 Merck Group Corporation Information
11.1.2 Merck Group Overview
11.1.3 Merck Group Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Group Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Group Recent Developments
11.2 BPS Bioscience, Inc.
11.2.1 BPS Bioscience, Inc. Corporation Information
11.2.2 BPS Bioscience, Inc. Overview
11.2.3 BPS Bioscience, Inc. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 BPS Bioscience, Inc. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BPS Bioscience, Inc. Recent Developments
11.3 Selleck Chemicals
11.3.1 Selleck Chemicals Corporation Information
11.3.2 Selleck Chemicals Overview
11.3.3 Selleck Chemicals Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Selleck Chemicals Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Selleck Chemicals Recent Developments
11.4 AdooQ BioScience
11.4.1 AdooQ BioScience Corporation Information
11.4.2 AdooQ BioScience Overview
11.4.3 AdooQ BioScience Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AdooQ BioScience Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AdooQ BioScience Recent Developments
11.5 Cayman Chemical Company
11.5.1 Cayman Chemical Company Corporation Information
11.5.2 Cayman Chemical Company Overview
11.5.3 Cayman Chemical Company Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cayman Chemical Company Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cayman Chemical Company Recent Developments
11.6 Santa Cruz Biotechnology, Inc.
11.6.1 Santa Cruz Biotechnology, Inc. Corporation Information
11.6.2 Santa Cruz Biotechnology, Inc. Overview
11.6.3 Santa Cruz Biotechnology, Inc. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Santa Cruz Biotechnology, Inc. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Santa Cruz Biotechnology, Inc. Recent Developments
11.7 Apexbio Technology LLC
11.7.1 Apexbio Technology LLC Corporation Information
11.7.2 Apexbio Technology LLC Overview
11.7.3 Apexbio Technology LLC Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Apexbio Technology LLC Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Apexbio Technology LLC Recent Developments
11.8 TargetMol Chemicals Inc
11.8.1 TargetMol Chemicals Inc Corporation Information
11.8.2 TargetMol Chemicals Inc Overview
11.8.3 TargetMol Chemicals Inc Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 TargetMol Chemicals Inc Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 TargetMol Chemicals Inc Recent Developments
11.9 InvivoChem LLC
11.9.1 InvivoChem LLC Corporation Information
11.9.2 InvivoChem LLC Overview
11.9.3 InvivoChem LLC Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 InvivoChem LLC Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 InvivoChem LLC Recent Developments
11.10 Cckinase, Inc.
11.10.1 Cckinase, Inc. Corporation Information
11.10.2 Cckinase, Inc. Overview
11.10.3 Cckinase, Inc. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Cckinase, Inc. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cckinase, Inc. Recent Developments
11.11 Shanghai lollane biological technology Co.,Ltd.
11.11.1 Shanghai lollane biological technology Co.,Ltd. Corporation Information
11.11.2 Shanghai lollane biological technology Co.,Ltd. Overview
11.11.3 Shanghai lollane biological technology Co.,Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Shanghai lollane biological technology Co.,Ltd. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shanghai lollane biological technology Co.,Ltd. Recent Developments
11.12 Shanghai Rechem science Co., Ltd.
11.12.1 Shanghai Rechem science Co., Ltd. Corporation Information
11.12.2 Shanghai Rechem science Co., Ltd. Overview
11.12.3 Shanghai Rechem science Co., Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Shanghai Rechem science Co., Ltd. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shanghai Rechem science Co., Ltd. Recent Developments
11.13 Dalian Meilun Biotech Co., Ltd.
11.13.1 Dalian Meilun Biotech Co., Ltd. Corporation Information
11.13.2 Dalian Meilun Biotech Co., Ltd. Overview
11.13.3 Dalian Meilun Biotech Co., Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Dalian Meilun Biotech Co., Ltd. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Dalian Meilun Biotech Co., Ltd. Recent Developments
11.14 Ningbo Inno Pharmchem Co., Ltd.
11.14.1 Ningbo Inno Pharmchem Co., Ltd. Corporation Information
11.14.2 Ningbo Inno Pharmchem Co., Ltd. Overview
11.14.3 Ningbo Inno Pharmchem Co., Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Ningbo Inno Pharmchem Co., Ltd. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Ningbo Inno Pharmchem Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Romidepsin Industry Chain Analysis
12.2 Romidepsin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Romidepsin Production Mode & Process
12.4 Romidepsin Sales and Marketing
12.4.1 Romidepsin Sales Channels
12.4.2 Romidepsin Distributors
12.5 Romidepsin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Romidepsin Industry Trends
13.2 Romidepsin Market Drivers
13.3 Romidepsin Market Challenges
13.4 Romidepsin Market Restraints
14 Key Findings in The Global Romidepsin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Romidepsin is a histone deacetylase (HDAC) inhibitor that is used in the treatment of cancer.
Market Analysis and Insights: Global Romidepsin Market
Due to the COVID-19 pandemic, the global Romidepsin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 0.98 accounting for % of the Romidepsin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Biological segment is altered to an % CAGR throughout this forecast period.
China Romidepsin market size is valued at US$ million in 2021, while the US and Europe Romidepsin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Romidepsin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Romidepsin include Merck Group, BPS Bioscience, Inc., Selleck Chemicals, AdooQ BioScience, Cayman Chemical Company, Santa Cruz Biotechnology, Inc., Apexbio Technology LLC, TargetMol Chemicals Inc and InvivoChem LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Romidepsin Scope and Segment
Romidepsin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Romidepsin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
0.98
>98%
Segment by Application
Biological
Medical
By Company
Merck Group
BPS Bioscience, Inc.
Selleck Chemicals
AdooQ BioScience
Cayman Chemical Company
Santa Cruz Biotechnology, Inc.
Apexbio Technology LLC
TargetMol Chemicals Inc
InvivoChem LLC
Cckinase, Inc.
Shanghai lollane biological technology Co.,Ltd.
Shanghai Rechem science Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Ningbo Inno Pharmchem Co., Ltd.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Romidepsin Product Introduction
1.2 Market by Type
1.2.1 Global Romidepsin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 0.98
1.2.3 >98%
1.3 Market by Application
1.3.1 Global Romidepsin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Biological
1.3.3 Medical
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Romidepsin Sales Estimates and Forecasts 2017-2028
2.2 Global Romidepsin Revenue Estimates and Forecasts 2017-2028
2.3 Global Romidepsin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Romidepsin Sales by Region
2.4.1 Global Romidepsin Sales by Region (2017-2022)
2.4.2 Global Sales Romidepsin by Region (2023-2028)
2.5 Global Romidepsin Revenue by Region
2.5.1 Global Romidepsin Revenue by Region (2017-2022)
2.5.2 Global Romidepsin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Romidepsin Sales by Manufacturers
3.1.1 Global Top Romidepsin Manufacturers by Sales (2017-2022)
3.1.2 Global Romidepsin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Romidepsin in 2021
3.2 Global Romidepsin Revenue by Manufacturers
3.2.1 Global Romidepsin Revenue by Manufacturers (2017-2022)
3.2.2 Global Romidepsin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Romidepsin Revenue in 2021
3.3 Global Romidepsin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Romidepsin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Romidepsin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Romidepsin Sales by Type
4.1.1 Global Romidepsin Historical Sales by Type (2017-2022)
4.1.2 Global Romidepsin Forecasted Sales by Type (2023-2028)
4.1.3 Global Romidepsin Sales Market Share by Type (2017-2028)
4.2 Global Romidepsin Revenue by Type
4.2.1 Global Romidepsin Historical Revenue by Type (2017-2022)
4.2.2 Global Romidepsin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Romidepsin Revenue Market Share by Type (2017-2028)
4.3 Global Romidepsin Price by Type
4.3.1 Global Romidepsin Price by Type (2017-2022)
4.3.2 Global Romidepsin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Romidepsin Sales by Application
5.1.1 Global Romidepsin Historical Sales by Application (2017-2022)
5.1.2 Global Romidepsin Forecasted Sales by Application (2023-2028)
5.1.3 Global Romidepsin Sales Market Share by Application (2017-2028)
5.2 Global Romidepsin Revenue by Application
5.2.1 Global Romidepsin Historical Revenue by Application (2017-2022)
5.2.2 Global Romidepsin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Romidepsin Revenue Market Share by Application (2017-2028)
5.3 Global Romidepsin Price by Application
5.3.1 Global Romidepsin Price by Application (2017-2022)
5.3.2 Global Romidepsin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Romidepsin Market Size by Type
6.1.1 North America Romidepsin Sales by Type (2017-2028)
6.1.2 North America Romidepsin Revenue by Type (2017-2028)
6.2 North America Romidepsin Market Size by Application
6.2.1 North America Romidepsin Sales by Application (2017-2028)
6.2.2 North America Romidepsin Revenue by Application (2017-2028)
6.3 North America Romidepsin Market Size by Country
6.3.1 North America Romidepsin Sales by Country (2017-2028)
6.3.2 North America Romidepsin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Romidepsin Market Size by Type
7.1.1 Europe Romidepsin Sales by Type (2017-2028)
7.1.2 Europe Romidepsin Revenue by Type (2017-2028)
7.2 Europe Romidepsin Market Size by Application
7.2.1 Europe Romidepsin Sales by Application (2017-2028)
7.2.2 Europe Romidepsin Revenue by Application (2017-2028)
7.3 Europe Romidepsin Market Size by Country
7.3.1 Europe Romidepsin Sales by Country (2017-2028)
7.3.2 Europe Romidepsin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Romidepsin Market Size by Type
8.1.1 Asia Pacific Romidepsin Sales by Type (2017-2028)
8.1.2 Asia Pacific Romidepsin Revenue by Type (2017-2028)
8.2 Asia Pacific Romidepsin Market Size by Application
8.2.1 Asia Pacific Romidepsin Sales by Application (2017-2028)
8.2.2 Asia Pacific Romidepsin Revenue by Application (2017-2028)
8.3 Asia Pacific Romidepsin Market Size by Region
8.3.1 Asia Pacific Romidepsin Sales by Region (2017-2028)
8.3.2 Asia Pacific Romidepsin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Romidepsin Market Size by Type
9.1.1 Latin America Romidepsin Sales by Type (2017-2028)
9.1.2 Latin America Romidepsin Revenue by Type (2017-2028)
9.2 Latin America Romidepsin Market Size by Application
9.2.1 Latin America Romidepsin Sales by Application (2017-2028)
9.2.2 Latin America Romidepsin Revenue by Application (2017-2028)
9.3 Latin America Romidepsin Market Size by Country
9.3.1 Latin America Romidepsin Sales by Country (2017-2028)
9.3.2 Latin America Romidepsin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Romidepsin Market Size by Type
10.1.1 Middle East and Africa Romidepsin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Romidepsin Revenue by Type (2017-2028)
10.2 Middle East and Africa Romidepsin Market Size by Application
10.2.1 Middle East and Africa Romidepsin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Romidepsin Revenue by Application (2017-2028)
10.3 Middle East and Africa Romidepsin Market Size by Country
10.3.1 Middle East and Africa Romidepsin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Romidepsin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck Group
11.1.1 Merck Group Corporation Information
11.1.2 Merck Group Overview
11.1.3 Merck Group Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Group Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Group Recent Developments
11.2 BPS Bioscience, Inc.
11.2.1 BPS Bioscience, Inc. Corporation Information
11.2.2 BPS Bioscience, Inc. Overview
11.2.3 BPS Bioscience, Inc. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 BPS Bioscience, Inc. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BPS Bioscience, Inc. Recent Developments
11.3 Selleck Chemicals
11.3.1 Selleck Chemicals Corporation Information
11.3.2 Selleck Chemicals Overview
11.3.3 Selleck Chemicals Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Selleck Chemicals Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Selleck Chemicals Recent Developments
11.4 AdooQ BioScience
11.4.1 AdooQ BioScience Corporation Information
11.4.2 AdooQ BioScience Overview
11.4.3 AdooQ BioScience Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AdooQ BioScience Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AdooQ BioScience Recent Developments
11.5 Cayman Chemical Company
11.5.1 Cayman Chemical Company Corporation Information
11.5.2 Cayman Chemical Company Overview
11.5.3 Cayman Chemical Company Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Cayman Chemical Company Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cayman Chemical Company Recent Developments
11.6 Santa Cruz Biotechnology, Inc.
11.6.1 Santa Cruz Biotechnology, Inc. Corporation Information
11.6.2 Santa Cruz Biotechnology, Inc. Overview
11.6.3 Santa Cruz Biotechnology, Inc. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Santa Cruz Biotechnology, Inc. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Santa Cruz Biotechnology, Inc. Recent Developments
11.7 Apexbio Technology LLC
11.7.1 Apexbio Technology LLC Corporation Information
11.7.2 Apexbio Technology LLC Overview
11.7.3 Apexbio Technology LLC Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Apexbio Technology LLC Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Apexbio Technology LLC Recent Developments
11.8 TargetMol Chemicals Inc
11.8.1 TargetMol Chemicals Inc Corporation Information
11.8.2 TargetMol Chemicals Inc Overview
11.8.3 TargetMol Chemicals Inc Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 TargetMol Chemicals Inc Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 TargetMol Chemicals Inc Recent Developments
11.9 InvivoChem LLC
11.9.1 InvivoChem LLC Corporation Information
11.9.2 InvivoChem LLC Overview
11.9.3 InvivoChem LLC Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 InvivoChem LLC Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 InvivoChem LLC Recent Developments
11.10 Cckinase, Inc.
11.10.1 Cckinase, Inc. Corporation Information
11.10.2 Cckinase, Inc. Overview
11.10.3 Cckinase, Inc. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Cckinase, Inc. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cckinase, Inc. Recent Developments
11.11 Shanghai lollane biological technology Co.,Ltd.
11.11.1 Shanghai lollane biological technology Co.,Ltd. Corporation Information
11.11.2 Shanghai lollane biological technology Co.,Ltd. Overview
11.11.3 Shanghai lollane biological technology Co.,Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Shanghai lollane biological technology Co.,Ltd. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shanghai lollane biological technology Co.,Ltd. Recent Developments
11.12 Shanghai Rechem science Co., Ltd.
11.12.1 Shanghai Rechem science Co., Ltd. Corporation Information
11.12.2 Shanghai Rechem science Co., Ltd. Overview
11.12.3 Shanghai Rechem science Co., Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Shanghai Rechem science Co., Ltd. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Shanghai Rechem science Co., Ltd. Recent Developments
11.13 Dalian Meilun Biotech Co., Ltd.
11.13.1 Dalian Meilun Biotech Co., Ltd. Corporation Information
11.13.2 Dalian Meilun Biotech Co., Ltd. Overview
11.13.3 Dalian Meilun Biotech Co., Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Dalian Meilun Biotech Co., Ltd. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Dalian Meilun Biotech Co., Ltd. Recent Developments
11.14 Ningbo Inno Pharmchem Co., Ltd.
11.14.1 Ningbo Inno Pharmchem Co., Ltd. Corporation Information
11.14.2 Ningbo Inno Pharmchem Co., Ltd. Overview
11.14.3 Ningbo Inno Pharmchem Co., Ltd. Romidepsin Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Ningbo Inno Pharmchem Co., Ltd. Romidepsin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Ningbo Inno Pharmchem Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Romidepsin Industry Chain Analysis
12.2 Romidepsin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Romidepsin Production Mode & Process
12.4 Romidepsin Sales and Marketing
12.4.1 Romidepsin Sales Channels
12.4.2 Romidepsin Distributors
12.5 Romidepsin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Romidepsin Industry Trends
13.2 Romidepsin Market Drivers
13.3 Romidepsin Market Challenges
13.4 Romidepsin Market Restraints
14 Key Findings in The Global Romidepsin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/30 10:26

143.57 円

163.67 円

195.09 円

ページTOPに戻る